Meet the team behind the questions
What Difference Does a Pediatric Proton Therapy Center Make?
If we are effective at replicating what we did in lab, we are looking at a cure for a disease that affects more than 100,000 people in the United States.

Punam Malik, MD on the potential of gene therapy as a sickle cell cure

Can Fetal Hemoglobin Therapy Actually Cure Sickle Cell Disease?
John Perentesis, MD, FAAP Director, Division of Oncology; Institute Co-Director, Cancer and Blood Diseases Institute; Deb Kleisinger Endowed Chair

See Info

John Perentesis, MD, FAAP

Director, Division of Oncology; Institute Co-Director, Cancer and Blood Diseases Institute; Deb Kleisinger Endowed Chair 513-636-8241 john.perentesis@cchmc.org
See Full Biography
Stella Davies, MBBS, PhD, MRCP Director, Division of Bone Marrow Transplantation and Immune Deficiency; Institute Co-Director, Cancer and Blood Diseases Institute; Jacob G. Schmidlapp Endowed Chair

See Info

Stella Davies, MBBS, PhD, MRCP

Director, Division of Bone Marrow Transplantation and Immune Deficiency; Institute Co-Director, Cancer and Blood Diseases Institute; Jacob G. Schmidlapp Endowed Chair 513-636-1371 stella.davies@cchmc.org
See Full Biography
Russell Ware, MD, PhD Director, Division of Hematology; Institute Co-Director, Cancer and Blood Diseases Institute; Associate Director, Global Health Center; Marjory J. Johnson Chair of Hematology Translational Research

See Info

Russell Ware, MD, PhD

Director, Division of Hematology; Institute Co-Director, Cancer and Blood Diseases Institute; Associate Director, Global Health Center; Marjory J. Johnson Chair of Hematology Translational Research 513-517-2344 russell.ware@cchmc.org
See Full Biography
How does Overexpression of TRAF6 Drive the Body’s Immune Response?
What is Happening on the Front Lines of ALL and AML Research?
What is the Connection Between Tumor Sequencing and Relapsed Cancers?
Yi Zheng, PhD Director, Experimental Hematology and Cancer Biology; Institute Co-Director, Cancer and Blood Diseases Institute; Katherine Stewart Waters Endowed Chair

See Info

Yi Zheng, PhD

Director, Experimental Hematology and Cancer Biology; Institute Co-Director, Cancer and Blood Diseases Institute; Katherine Stewart Waters Endowed Chair 513-636-0595 yi.zheng@cchmc.org
See Full Biography